浮针疗法治疗早期强直性脊柱炎疗效观察

Observations on the Efficacy of Superficial Needling Therapy for Early Ankylosing Spondylitis

目的观察浮针疗法对早期强直性脊柱炎的临床疗效及其对肿瘤坏死因子-?(TNF-?)、白介素-1(IL-1)、白介素-6(IL-6)的影响。方法将80例符合纳入标准的早期强直性脊柱炎患者采用随机卡法按1:1分为治疗组和对照组,每组40例。治疗组予单纯浮针治疗,对照组予塞来昔布胶囊、甲氨蝶呤片、柳氮磺吡啶肠溶片常规治疗,共治疗24星期。观察两组治疗前后Bath AS疾病活动指数(BASDAI)、Bath AS功能指数(BASFI)、腰痛指数、中医证候评分及TNF-?、IL-1、IL-6等指标的变化情况。结果两组治疗后BASDAI、BASFI、腰痛指数、中医证候评分及TNF-?、IL-1、IL-6水平较同组治疗前均有改善(P<0.05),且治疗组治疗后BASDAI、BASFI、腰痛指数、中医证候评分及TNF-?、IL-1、IL-6水平优于对照组(P<0.05)。结论浮针疗法能缓解早期强直性脊柱炎患者临床症状,改善脊柱关节功能且安全性良好,其机制可能与降低炎性细胞因子TNF-?、IL-1、IL-6的水平相关。

Objective To investigate the clinical efficacy of superficial needling therapy for early ankylosing spondylitis and its effect on tumor necrosis factor-α （TNF-α）, interleukin-1 （IL-1） and interleukin-6 （IL-6）. Methods Eighty patients with early ankylosing spondylitis meeting the inclusion criteria were randomly allocated to treatment and control groups using random number card method with the ratio of 1：1, 40 cases each. The treatment group received superficial needling therapy alone and the control group, conventional treatment with celecoxib capsules, methotrexate tablets and sulfasalazine enteric-coated tablets. Treatment was given for a total of 24 weeks. Bath AS Disease Activity Index （BASDAI）, Bath AS Functional Index （BASFI）, lumbago, TCM syndrome score, TNF-α, IL-1 and IL-6 were observed in the two groups before and after treatment. Results The BASDAI, BASFI, lumbago, TCM syndrome score, TNF-α, IL-1 and IL-6 improved in the two groups after treatment compared with those before the treatment （P〈0.05）. The BASDAI, BASFI, lumbago, TCM syndrome score, TNF-α, IL-1 and IL-6 in the treatment group superior to those in the control group after the treatment （P〈0.05）. Conclusions Superficial needling therapy can relieve the clinical symptoms in patients with early ankylosing spondylitis and improve spinal joint function with good safety. Its mechanism may be related to reducing inflammatory cytokines TNF-α, IL-1 and IL-6.